# Nuclide record mariana-oncology (company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/companies/mariana-oncology/>
  a schema:Organization ;
  nuclide:kind "company" ;
  schema:identifier "mariana-oncology" ;
  schema:name "Mariana Oncology"@en ;
  schema:description "Mariana Oncology designs small protein fragments that carry a radioactive isotope to tumours, starting with small cell lung cancer. Novartis bought the company in 2024 for 1 billion dollars up front."@en ;
  schema:url <https://nuclide.cc/companies/mariana-oncology/>, <https://marianaoncology.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://marianaoncology.com/>, <https://marianaoncology.com/news/mariana-oncology-announces-usd175-million-series-b-financing/>, <https://marianaoncology.com/news/mariana-oncology-to-be-acquired-by-novartis-to-advance-precision-radiopharmaceuticals-to-treat-cancer/> ;
  schema:addressCountry "US" ;
  nuclide:indications <https://nuclide.cc/indications/sclc/> ;
  nuclide:technologies <https://nuclide.cc/technologies/radioligand-therapy/> .